Articles

Dasatinib response in acute myeloid leukemia is correlated with FLT3/ITD, PTPN11 mutations and a unique gene expression signature

Hemato-Oncology Department, Assuta Medical Center, Tel Aviv, Israel;
G-INCPM, Weizmann Institute of Science, Rehovot, Israel;
Department of Immunology, Weizmann Institute of Science, Rehovot, Israel;
Department of Immunology, Weizmann Institute of Science, Rehovot, Israel;
Department of Immunology, Weizmann Institute of Science, Rehovot, Israel;
Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel;
G-INCPM, Weizmann Institute of Science, Rehovot, Israel;
Princess Margaret Cancer Centre, University Health Network (UHN) Toronto, Canada;
G-INCPM, Weizmann Institute of Science, Rehovot, Israel;
Division of Hematology and Hematologic Malignancies, University of Utah, Salt Lake City, UT, USA
Department of Immunology, Weizmann Institute of Science, Rehovot, Israel;
Department of Immunology, Weizmann Institute of Science, Rehovot, Israel;
Haematologica Early view May 21, 2020 https://doi.org/10.3324/haematol.2019.240705